Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Leukemia|February 24, 2023
Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemiaHasan Issa, Laura E Swart, Milad Rasouli, et al.
Frontiers in Medicine|June 17, 2026
Advances in AI-based diagnosis of Alzheimer's disease using MRI: a comprehensive surveyHasan Issa Raheem Alyaqoobi, Jose Manuel Lopez-Guede, Omer Asghar Dara, et al.
Iscience|September 28, 2023
Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus <i>MYNRL15</i>Michelle Ng, Lonneke Verboon, Hasan Issa, et al.
Blood|September 27, 2021
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesisOriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, et al.
Blood Advances|April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid LeukemiaLonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Blood|October 21, 2025
CPX-351 in Down syndrome-associated Myeloid Leukemia: Results and Prognostic Factors from the Phase 3 ML-DS 2018 TrialStephanie Laszig, Antonia Diederichs, Emilia Salzmann-Manrique, et al.
Nature Communications|April 23, 2026
Single cell transcriptional evolution of myeloid leukemia of Down syndromeMi K Trinh, Konstantin Schuschel, Hasan Issa, et al.
Blood|December 9, 2022
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemiaSofia Gialesaki, Daniela Bräuer-Hartmann, Hasan Issa, et al.
Cancer Cell|October 10, 2018
The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic TransformationNatalia Martinez-Soria, Lynsey McKenzie, Julia Draper, et al.
Pageof 1